🇺🇸 FDA
Patent

US 11173146

Selective activators of the intermediate conductance CA2+activated K+ channel KCa3.1 and their methods of use

granted A61KA61K31/404A61K31/423

Quick answer

US patent 11173146 (Selective activators of the intermediate conductance CA2+activated K+ channel KCa3.1 and their methods of use) held by The Regents of the University of California expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/404, A61K31/423, A61K31/428, A61P